You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

SULFASALAZINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Sulfasalazine

A generic version of SULFASALAZINE was approved as sulfasalazine by WATSON LABS on December 31st, 1969.

  Try a Trial

Drug patent expirations by year for SULFASALAZINE
Drug Prices for SULFASALAZINE

See drug prices for SULFASALAZINE

Drug Sales Revenue Trends for SULFASALAZINE

See drug sales revenues for SULFASALAZINE

Recent Clinical Trials for SULFASALAZINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rutgers, The State University of New JerseyPhase 2
University of ZurichPhase 1/Phase 2
Swiss National Science FoundationPhase 1/Phase 2

See all SULFASALAZINE clinical trials

Pharmacology for SULFASALAZINE
Drug ClassAminosalicylate

US Patents and Regulatory Information for SULFASALAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nuvo Pharms Inc SULFASALAZINE sulfasalazine TABLET, DELAYED RELEASE;ORAL 075339-001 Jan 11, 2002 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Superpharm SULFASALAZINE sulfasalazine TABLET;ORAL 089339-001 Oct 26, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Epic Pharma Llc SULFASALAZINE sulfasalazine TABLET;ORAL 086184-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs SULFASALAZINE sulfasalazine TABLET;ORAL 084964-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs SULFASALAZINE sulfasalazine TABLET, DELAYED RELEASE;ORAL 088052-001 May 24, 1983 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.